HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jens P Klussmann Selected Research
Jens P Klussmann Research Topics
Disease
25
Neoplasms (Cancer)
10/2021 - 03/2003
16
Squamous Cell Carcinoma of Head and Neck
10/2021 - 08/2003
6
Carcinoma (Carcinomatosis)
01/2018 - 03/2003
3
Papillomavirus Infections
05/2014 - 01/2005
3
Neoplasm Metastasis (Metastasis)
05/2013 - 08/2003
2
Head and Neck Neoplasms (Head and Neck Cancer)
12/2019 - 01/2015
2
Carcinogenesis
10/2017 - 06/2015
2
Infections
01/2017 - 01/2015
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015 - 05/2014
2
Salivary Gland Neoplasms (Salivary Gland Cancer)
04/2012 - 05/2011
2
Lymphatic Metastasis
02/2012 - 06/2011
2
Oropharyngeal Neoplasms
04/2007 - 02/2004
1
Inflammation (Inflammations)
12/2020
1
Residual Neoplasm
11/2020
1
Disease Progression
11/2020
1
Hypoxia (Hypoxemia)
10/2017
1
Papilloma (Papillomatosis)
05/2014
1
Acinar Cell Carcinoma
04/2012
1
Tonsillar Neoplasms
06/2011
1
Tonsillitis
06/2010
1
Snoring
06/2010
1
Pleomorphic Adenoma
08/2006
1
Epidermodysplasia Verruciformis
08/2003
1
Hypopharyngeal Neoplasms
08/2003
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
08/2003
1
Laryngeal Neoplasms (Laryngeal Cancer)
08/2003
Drug/Important Bio-Agent (IBA)
10
DNA (Deoxyribonucleic Acid)
IBA
11/2020 - 03/2003
8
Biomarkers (Surrogate Marker)
IBA
12/2020 - 03/2003
7
Proteins (Proteins, Gene)
FDA Link
01/2019 - 03/2003
4
Indicators and Reagents (Reagents)
IBA
01/2019 - 03/2009
3
Paraffin
IBA
12/2020 - 04/2003
3
Viral DNA
IBA
03/2015 - 03/2003
2
Oncogene Proteins (Oncogene Protein)
IBA
10/2017 - 01/2015
2
Aldehyde Dehydrogenase 1 Family
IBA
07/2014 - 05/2013
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
05/2014 - 06/2010
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
10/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
12/2020
1
Immune Checkpoint Proteins
IBA
12/2020
1
Immune Checkpoint Inhibitors
IBA
12/2020
1
Antibodies
IBA
12/2020
1
Biological Products
IBA
12/2019
1
Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)
IBA
12/2019
1
Antigens
IBA
01/2019
1
Aldo-Keto Reductases
IBA
01/2019
1
Carcinogens
IBA
01/2017
1
oligomycin sensitivity-conferring protein (complex V)
IBA
11/2015
1
Lactic Acid (Lactate)
FDA Link
Generic
11/2015
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
11/2015
1
Mitochondrial DNA (mtDNA)
IBA
11/2015
1
Adenosine Triphosphate (ATP)
IBA
11/2015
1
Glucose (Dextrose)
FDA Link
Generic
11/2015
1
human MIRN452 microRNA
IBA
03/2015
1
human MIRN214 microRNA
IBA
03/2015
1
MicroRNAs (MicroRNA)
IBA
03/2015
1
Cisplatin (Platino)
FDA Link
Generic
01/2015
1
Cyclin A2
IBA
01/2015
1
Cyclins
IBA
01/2015
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
04/2012
1
Catenins
IBA
06/2011
1
Vimentin
IBA
06/2011
1
Cell Adhesion Molecules
IBA
06/2011
1
Cadherins (E-Cadherin)
IBA
06/2011
1
Survivin
IBA
05/2011
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
02/2011
1
Messenger RNA (mRNA)
IBA
02/2011
1
ErbB Receptors (EGF Receptor)
IBA
04/2007
1
Formaldehyde (Formol)
FDA Link
04/2003
Therapy/Procedure
8
Therapeutics
10/2021 - 05/2011
2
Lasers (Laser)
08/2003 - 03/2003
1
Chemoradiotherapy
10/2021
1
Investigational Therapies (Experimental Therapy)
01/2021
1
Precision Medicine
10/2020
1
Drug Therapy (Chemotherapy)
01/2015
1
Radiotherapy
03/2012
1
Neck Dissection (Radical Neck Dissection)
02/2012
1
Tonsillectomy
06/2010